Why SafeFine

Other Products

Insulin pen needles are supplied in carton boxes. Since there is no waste control system in place for disposal of these products, used needles are often disposed via household waste in an uncontrolled manner. This leaves patients open to infections and transmissible diseases.

SafeFine

Thanks to the plastic outer package, our product is delivered to patients without causing any damage to its packaging. The product box has two separate compartments. Unused needles are located at the bottom of the box, whereas used needles are detached from the pen after being used and stored into the sealed waste compartment into which they fall. Thus, waste container is discarded together with the product in a controlled manner to prevent potential undesired situations arising from infected needles.

Marketing

Just to give you a general idea on the global market share of insulin needles, let us share with you the following:

  • Each insulin needle tip package contains 100 insulin needle tips.
  • Patients on insulin therapy use an average of 10 boxes of insulin pen needles per year.
  • This corresponds to a global market of approximately 260 million boxes.
  • Obviously, there is a rapidly growing need for insulin needles due to increasing population of diabetic patients worldwide.

Diabetes in Europe

52000000

Total diabetes patients in Europe

500000

Insulin pen needle is used.

450000

It is disposed with household waste

2000

Daily we are experiencing cases of needle stick

According to the IDF Diabetes Atlas data, there are 52 million people living with diabetes in Europe.*
As a whole, diabetic patients use more than 500 million insulin pen needles per day. Almost all of these needles are disposed via household wastes.
Used needles are exposed to contamination by bacteria that cause infectious diseases and pose a danger for the environment, humans and animals.

*IDF 2014 Diabetes Atlas. www.idf.org/diabetesatlas